Literature DB >> 12752495

Marked improvement of glycaemic control with pioglitazone in a Type 2 diabetic patient associated with Charcot-Marie-Tooth disease.

T Ota, K Osawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752495     DOI: 10.1046/j.1464-5491.2003.009173.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  5 in total

1.  Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.

Authors:  Zhiliang Yu; Xiaohua Wu; Huijun Xie; Ying Han; Yangtai Guan; Yong Qin; Huimin Zheng; Jianming Jiang; Zhenmin Niu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age.

Authors:  Judith Eschbach; Jérôme Sinniger; Jamal Bouitbir; Anissa Fergani; Anna-Isabel Schlagowski; Joffrey Zoll; Bernard Geny; Frédérique René; Yves Larmet; Vincent Marion; Robert H Baloh; Matthew B Harms; Michael E Shy; Nadia Messadeq; Patrick Weydt; Jean-Philippe Loeffler; Albert C Ludolph; Luc Dupuis
Journal:  Neurobiol Dis       Date:  2013-06-04       Impact factor: 5.996

Review 3.  Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.

Authors:  Loutfi S Aboussouan; Richard A Lewis; Michael E Shy
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

4.  Coexistent Charcot-Marie-Tooth type 1A and type 2 diabetes mellitus neuropathies in a Chinese family.

Authors:  A-Ping Sun; Lu Tang; Qin Liao; Hui Zhang; Ying-Shuang Zhang; Jun Zhang
Journal:  Neural Regen Res       Date:  2015-10       Impact factor: 5.135

5.  A case report of hereditary neuropathy with liability to pressure palsies accompanied by type 2 diabetes mellitus and psoriasis.

Authors:  Jing Li; Bing Niu; Xiaoling Wang; Huaiqiang Hu; Bingzhen Cao
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.